Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel S Perlmutter

Showing results (1-10 of 354) with videos related to

Pageof 36
Sort By:
Neurology|June 6, 2014
Comment: fMRI biomarker for premanifest HD?Joel S Perlmutter
Narrative Inquiry in Bioethics|January 11, 2014
Expert testimony at the Food and Drug Administration: who wants the truth?Joel S Perlmutter
Narrative Inquiry in Bioethics|August 1, 2022
Bidding for a Grateful PatientJoel S Perlmutter
Nature Medicine|August 20, 2021
Aducanumab: look before leapingJoel S Perlmutter
Current Protocols in Neuroscience|October 6, 2009
Assessment of Parkinson disease manifestationsJoel S Perlmutter
Annals of Internal Medicine|September 20, 2021
Moving the U.S. Food and Drug Administration ForwardJoel S Perlmutter
Neurology|September 16, 2025
Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS): Still Mountains to ClimbBaijayanta Maiti, Joel S Perlmutter
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|February 26, 2015
The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimagingMorvarid Karimi, Joel S Perlmutter
Annals of Internal Medicine|April 1, 2020
A Clinical Trial of Isradipine: What Went Wrong?Baijayanta Maiti, Joel S Perlmutter
Neurology|February 11, 2012
To scan or not to scan: DaT is the questionJoel S Perlmutter, David Eidelberg
Pageof 36

Showing results (1-10 of 354) with videos related to

Sort By:
Pageof 36
Neurology|June 6, 2014
Comment: fMRI biomarker for premanifest HD?Joel S Perlmutter
Narrative Inquiry in Bioethics|January 11, 2014
Expert testimony at the Food and Drug Administration: who wants the truth?Joel S Perlmutter
Narrative Inquiry in Bioethics|August 1, 2022
Bidding for a Grateful PatientJoel S Perlmutter
Nature Medicine|August 20, 2021
Aducanumab: look before leapingJoel S Perlmutter
Current Protocols in Neuroscience|October 6, 2009
Assessment of Parkinson disease manifestationsJoel S Perlmutter
Annals of Internal Medicine|September 20, 2021
Moving the U.S. Food and Drug Administration ForwardJoel S Perlmutter
Neurology|September 16, 2025
Diffusion Tensor Imaging Along the Perivascular Space (DTI-ALPS): Still Mountains to ClimbBaijayanta Maiti, Joel S Perlmutter
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|February 26, 2015
The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimagingMorvarid Karimi, Joel S Perlmutter
Annals of Internal Medicine|April 1, 2020
A Clinical Trial of Isradipine: What Went Wrong?Baijayanta Maiti, Joel S Perlmutter
Neurology|February 11, 2012
To scan or not to scan: DaT is the questionJoel S Perlmutter, David Eidelberg
Pageof 36